MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER

被引:0
|
作者
CULLEN, MH
CHETIYAWARDANA, AD
JOSHI, R
WOODROFFE, CM
机构
[1] QUEEN ELIZABETH HOSP,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
[2] MANOR HOSP,WALSALL,STAFFS,ENGLAND
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:259 / 259
页数:1
相关论文
共 50 条
  • [21] IFOSFAMIDE, MITOMYCIN-C AND VINDESINE ADAPTED TO THE PERFORMANCE STATUS IN DISSEMINATED NON-SMALL CELL LUNG-CANCER
    RUGER, I
    SCHROEDER, M
    PUREA, H
    WESTERHAUSEN, M
    IFOSFAMIDE IN THE TREATMENT OF LUNG CANCER, 1989, 35 : 106 - 107
  • [22] CHEMOTHERAPY OF ADVANCED NON-SMALL CELL LUNG-CANCER WITH IFOSFAMIDE AND VINDESINE
    DRINGS, P
    DJAWID, N
    BULZEBRUCK, H
    MEIERSCHWICKERATH, E
    TESSEN, HW
    IFOSFAMIDE IN THE TREATMENT OF LUNG CANCER, 1989, 35 : 91 - 102
  • [23] IFOSFAMIDE BY BOLUS AS TREATMENT FOR ADVANCED NON-SMALL CELL LUNG-CANCER
    THATCHER, N
    ANDERSON, H
    SMITH, DB
    STEWARD, WP
    WEBB, K
    HILTON, A
    RAHMAN, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 : S30 - S33
  • [24] MITOMYCIN-C, VINBLASTINE AND CISPLATIN - AN ACTIVE REGIMEN FOR ADVANCED NON-SMALL CELL LUNG-CANCER
    GIACCONE, G
    BAGATELLA, M
    DONADIO, M
    BONARDI, GM
    TESTORE, F
    FERRATI, P
    CIUFFREDA, L
    CALCIATI, A
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 475 - 478
  • [25] CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER WITH CISPLATIN AND VINDESINE
    DRINGS, P
    KLECKOW, M
    MANKE, HG
    STIEFEL, E
    ONKOLOGIE, 1984, 7 (04): : 202 - 204
  • [26] Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer
    Tonato, M
    Crino, L
    Mosconi, AM
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 831 - 835
  • [27] A PILOT-STUDY OF MITOMYCIN, IFOSFAMIDE AND CISPLATIN AS OUTPATIENT COMBINATION CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER
    MARIANI, GL
    PENNUCCI, MC
    ADDAMO, G
    VENTURINI, M
    ARDIZZONI, A
    ROSSO, R
    TUMORI, 1991, 77 (06) : 511 - 513
  • [28] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [29] PILOT-STUDY OF NEOADJUVANT IFOSFAMIDE, CISPLATIN, AND ETOPOSIDE IN LOCALLY ADVANCED NON-SMALL CELL LUNG-CANCER
    PUJOL, JL
    ROSSI, JF
    LECHEVALIER, T
    DAURES, JP
    ROUANET, P
    DOUILLARD, JY
    DUBOIS, JB
    ARRIAGADA, R
    MARY, H
    GODARD, P
    MICHEL, FB
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 798 - 801
  • [30] Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer
    Barone, C
    Corsi, DC
    Pozzo, C
    Cassano, A
    Alvaro, G
    Colloca, G
    Landriscina, M
    Astone, A
    ONCOLOGY, 2000, 58 (01) : 25 - 30